1![spin-out companies asklepios biopharmaceutical Therapeutic | askbio.com Asklepios BioPharmaceutical Inc., (“AskBio”) is a biotechnology company co-founded by R. Jude Samulski, spin-out companies asklepios biopharmaceutical Therapeutic | askbio.com Asklepios BioPharmaceutical Inc., (“AskBio”) is a biotechnology company co-founded by R. Jude Samulski,](https://www.pdfsearch.io/img/f5c06cd03f33d5751f4859abadb80850.jpg) | Add to Reading ListSource URL: partnerships.unc.eduLanguage: English - Date: 2014-06-23 12:00:32
|
---|
2![Breakthrough for treatment of cancer, and other diseases InteRNA Technologies BV is a Utrecht based biotech company that is developing new therapeutics for cancer and other diseases. The approach is based on science deve Breakthrough for treatment of cancer, and other diseases InteRNA Technologies BV is a Utrecht based biotech company that is developing new therapeutics for cancer and other diseases. The approach is based on science deve](https://www.pdfsearch.io/img/3617aac30b2cd054dfe45b121f5162eb.jpg) | Add to Reading ListSource URL: www.innovatieindezorg.comLanguage: English - Date: 2014-06-19 03:55:46
|
---|
3![Assessing unintended hybridization induced biological effects of oligonucleotides Assessing unintended hybridization induced biological effects of oligonucleotides](https://www.pdfsearch.io/img/8936933da0d92739983643e92d9317bf.jpg) | Add to Reading ListSource URL: osp.od.nih.govLanguage: English - Date: 2014-01-08 14:21:08
|
---|
4![Oligonucleotide drug discovery at Santaris Pharma + emphasis on specificity Oligonucleotide drug discovery at Santaris Pharma + emphasis on specificity](https://www.pdfsearch.io/img/2436acd2dd9ea2e37ba617fc0a69ad68.jpg) | Add to Reading ListSource URL: osp.od.nih.govLanguage: English - Date: 2014-01-08 14:21:16
|
---|
5![RNA OLIGONUCLEOTIDES: EMERGING CLINICAL APPLICATIONS NATIONAL INSTITUTES OF HEALTH HILTON HOTEL, ROCKVILLE, MARYLAND DECEMBER 15-16, 2011 AGENDA RNA OLIGONUCLEOTIDES: EMERGING CLINICAL APPLICATIONS NATIONAL INSTITUTES OF HEALTH HILTON HOTEL, ROCKVILLE, MARYLAND DECEMBER 15-16, 2011 AGENDA](https://www.pdfsearch.io/img/ae4539456910ef46d02de748386a417a.jpg) | Add to Reading ListSource URL: osp.od.nih.govLanguage: English - Date: 2014-03-20 16:29:33
|
---|
6![Santaris Pharma A/S Phase 2a data of miravirsen shows dose-dependent, prolonged viral reduction of 2-3 logs HCV RNA after four-week treatment in Hepatitis C patients -- New Phase 2a clinical data to be presented in late-breaking oral presentation at AASLD – Santaris Pharma A/S Phase 2a data of miravirsen shows dose-dependent, prolonged viral reduction of 2-3 logs HCV RNA after four-week treatment in Hepatitis C patients -- New Phase 2a clinical data to be presented in late-breaking oral presentation at AASLD –](https://www.pdfsearch.io/img/ad0e951cb5d29d88668ad32569bcb8cc.jpg) | Add to Reading ListSource URL: www.santaris.comLanguage: English - Date: 2011-11-05 11:55:33
|
---|
7![](https://www.pdfsearch.io/img/cb71298ab15303901a0e44630d2b4250.jpg) | Add to Reading ListSource URL: www.ebiotrade.comLanguage: English - Date: 2009-05-08 04:08:20
|
---|